Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lululemon Athletica | LULU | Jan 16, 2025 | 370.99 | -1.51 |
Lulus Fashion Lounge | LVLU | Jan 16, 2025 | 0.95 | -2.56 |
Lumen Technologies | LUMN | Jan 16, 2025 | 5.53 | -0.36 |
Lument Finance Trust | LFT | Jan 16, 2025 | 2.61 | +0.77 |
Lument Finance Trust A Pref | LFT-A | Jan 16, 2025 | 22.51 | 0.00 |
Lumentum | LITE | Jan 16, 2025 | 89.36 | +1.09 |
Luminar Technologies A | LAZR | Jan 16, 2025 | 6.90 | -7.63 |
Luna Innovations | LUNA | Jan 16, 2025 | 2.05 | 0.00 |
Luokung Technology | LKCO | Jan 16, 2025 | 1.77 | -11.06 |
Luxfer | LXFR | Jan 16, 2025 | 13.38 | +0.98 |
LuxUrban Hotels | LUXH | Jan 16, 2025 | 0.69 | 0.00 |
Luxurban Hotels Pref | LUXHP | Jan 16, 2025 | 14.03 | 0.00 |
Lxp Industrial Trust | LXP | Jan 16, 2025 | 8.20 | +2.37 |
LXP Industrial Trust C Pref | LXP-C | Jan 16, 2025 | 47.90 | -1.76 |
Lyell Immunopharma | LYEL | Jan 16, 2025 | 0.56 | -6.41 |
Lyft A | LYFT | Jan 16, 2025 | 13.60 | +1.49 |
LyondellBasell Industries Nv A | LYB | Jan 16, 2025 | 76.63 | +0.72 |
Lyra Therapeutics | LYRA | Jan 16, 2025 | 0.19 | -1.01 |
Lytus Technologies | LYT | Jan 16, 2025 | 0.64 | -4.16 |
M&T Bank | MTB | Jan 16, 2025 | 196.10 | -2.37 |
M&T Bank ADR Prej J | MTB-J | Jan 16, 2025 | 26.75 | 0.00 |
M&T Bank H Pref | MTB-H | Jan 16, 2025 | 24.77 | +0.36 |
M-tron Industries | MPTI | Jan 16, 2025 | 53.51 | -2.09 |
M/I Homes | MHO | Jan 16, 2025 | 137.02 | -0.24 |
M3-Brigade Acquisition V | MBAV | Jan 16, 2025 | 10.08 | 0.00 |
M3-Brigade Acquisition V | MBAVU | Jan 16, 2025 | 10.14 | 0.00 |
MAC Copper | MTAL | Jan 16, 2025 | 10.75 | +3.07 |
Macerich | MAC | Jan 16, 2025 | 19.52 | -0.31 |
Mach Natural Resources LP | MNR | Jan 16, 2025 | 17.61 | +0.06 |
Mackenzie Realty Capital Inc COM | MKZR | Jan 16, 2025 | 2.73 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.